Skip to content

Role of of Kshara Karma And Rasakriya In The Management Of Dushtavrana

A Randomized Controlled Trial To Evaluate The Efficacy of Kshara Karma And Rasakriya In The Management Of Dushtavrana

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027443
Enrollment
135
Registered
2020-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Kshara karma and Rasakriya: Group B Dose - Quantity sufficient Route of administration - External i.e Palasha Pratisaraneeya Kshara will be applied directly to the wound bed covered wit

Sponsors

Dr ASMA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient age: 18 years to 60 years of either gender 2. Patients having clinical features of Dushta Vrana i.e. foul smell, pus discharge, pain, oedema etc will be selected for study 3. Wound size: Within 6x6 cm 4. Wound depth: â?? Extends through both the epidermis and dermis, with no exposed tendon or bone 5. Wound duration: â?? More than 7 days 6. Wound bed characteristics: â?? Wound bed with slough/necrotic tissue and exudate 7. Venous ulcer, Ischemic ulcer, Trophic ulcer, Neurogenic ulcer, Tropical ulcer, Traumatic wounds

Exclusion criteria

Exclusion criteria: 1.Exposed bone, tendon or facia, Ulcer associated with Osteomyelitis 2.Systemic diseases like Diabetes, Tuberculosis, Syphilis, Leprosy, Malignancy, HIV, HbsAg 3.Burn wounds, Anaemia (Hb% 4.Patient suffering from signs of Cellulitis and Gangrene 5.Receiving corticosteroids or immune suppressive drugs

Design outcomes

Primary

MeasureTime frame
Kshara karma and Rasakriya if proved more efficacious i.e., to convert an untidy wound into a tidy wound, then it would help in treating Dushtavrana more efficiently.Timepoint: 2 years

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDrAsma

Professor, department of Shalyatantra

dr.omprakashdave@gmail.com946077626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026